Integrated BioPharma Reports Results for Its Quarter Ended December 31, 2025
HILLSIDE, NJ / ACCESS Newswire / February 11, 2026 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended December 31, 2025.Revenue for the quarter ended December 31, 2025 was $11.3 …
Weiterlesen »